Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - NET INCOME
Net Income NBIX - Neurocrine Biosciences, Inc.
341 M
LAST VALUE
48.63%
2 YEAR CAGR
55.94%
5 YEAR CAGR
22.54%
10 YEAR CAGR